Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia

scientific article published on August 2014

Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/FPC.0000000000000069
P698PubMed publication ID25007187

P2093author name stringNathalie K Zgheib
Miguel R Abboud
Samar A Muwakkit
Rami Mahfouz
Hassan Solh
Maya Akra-Ismail
Carol Aridi
P433issue8
P921main subjectmethotrexateQ422232
LebanonQ822
leukemiaQ29496
P304page(s)387-396
P577publication date2014-08-01
P1433published inPharmacogenetics and GenomicsQ10534561
P1476titleGenetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia
P478volume24

Reverse relations

cites work (P2860)
Q33707782ABCB1 genetic variants in leukemias: current insights into treatment outcomes
Q60916021ATP-Binding Cassette Transporters in the Clinical Implementation of Pharmacogenetics
Q99237781Analysis of Drug Metabolizing Gene Panel in Osteosarcoma Patients Identifies Association Between Variants in SULT1E1, CYP2B6 and CYP4F8 and Methotrexate Levels and Toxicities
Q49703642Association between SLC19A1 Gene Polymorphism and High Dose Methotrexate Toxicity in Childhood Acute Lymphoblastic Leukaemia and Non Hodgkin Malignant Lymphoma: Introducing a Haplotype based Approach
Q88493466Associations between the C677T and A1298C polymorphisms of MTHFR and the toxicity of methotrexate in childhood malignancies: a meta-analysis
Q26786582Development of Human Membrane Transporters: Drug Disposition and Pharmacogenetics
Q90049896ITPA, TPMT, and NUDT15 Genetic Polymorphisms Predict 6-Mercaptopurine Toxicity in Middle Eastern Children With Acute Lymphoblastic Leukemia
Q38651234Impact of Genetic Polymorphisms on Phenytoin Pharmacokinetics and Clinical Outcomes in the Middle East and North Africa Region.
Q39230513MTHFR polymorphisms in childhood acute lymphoblastic leukemia: influence on methotrexate therapy.
Q36302719Methylation level of CpG islands in GGH gene promoter in pediatric acute leukemia
Q38895172Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children With Acute Lymphoblastic Leukemia
Q28068930Pharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical Use
Q33914131Polymorphisms in methotrexate transporters and their relationship to plasma methotrexate levels, toxicity of high-dose methotrexate, and outcome of pediatric acute lymphoblastic leukemia
Q96954627Polymorphisms of SLC19A1 80 G>A, MTHFR 677 C>T, and Tandem TS Repeats Influence Pharmacokinetics, Acute Liver Toxicity, and Vomiting in Children With Acute Lymphoblastic Leukemia Treated With High Doses of Methotrexate
Q40959378TS Gene Polymorphisms Correlate with Susceptibility to Acute Lymphocytic Leukemia in Children.

Search more.